Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rare Earth Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105418502B details a novel rare earth catalyzed route for high-purity Paroxetine intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN115044052B reveals recyclable rare earth MOF catalyst for solvent-free silylcyanation. Enhances supply chain reliability and reduces manufacturing costs for pharma intermediates.
Patent CN108530331B details a rare earth amide catalyzed method for thiocarbamate synthesis offering high purity and mild conditions for pharmaceutical and agrochemical intermediate manufacturing.
Patent CN106423281B reveals rare earth silamide catalysis for high-yield spiro compound synthesis, offering cost-effective scalable manufacturing solutions.
Patent CN1303077C details a rare earth-catalyzed taxane synthesis using THF, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN110156873B reveals a novel NdSe2-catalyzed route for Fmoc-D-Pro-D-Pro-OH, offering >98.5% purity and streamlined manufacturing for peptide intermediates.
Novel rare earth silamide catalyst enables high-yield indole production from indolinones, offering significant cost and supply chain advantages for global manufacturers.
Novel rare-earth arylamine compounds enable high-yield synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing globally.
Advanced catalytic method for paroxetine intermediate synthesis. Enhances optical purity and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN110818733B reveals a high-efficiency disilylamine rare earth complex for hydroboration, offering cost reduction and scalable manufacturing for fine chemical intermediates.
Patent CN112961166A reveals a novel rare-earth catalyzed one-pot route for pyrano[2,3-b]indol-2-ones, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114989042A reveals high-yield rare earth catalyst for PDC. Enables green non-phosgene PDI manufacturing with substantial cost and supply chain advantages.
Patent CN110240551B reveals a high-yield catalytic route for Fmoc-beta-Ala-Gly-OH, offering superior purity and cost efficiency for peptide manufacturing.
Patent CN103232400A discloses a solvent-free rare earth catalyzed route for quinazoline-2-thiones, offering high yields and simplified purification for pharmaceutical intermediates.
Patent CN105837544B details a rare earth catalyzed synthesis offering high purity and environmental safety for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN105837544B details a green synthesis route for coumarin derivatives using rare earth catalysts, offering supply chain stability and cost efficiency.
Patent CN111892559B details a high-yield asymmetric epoxidation of chalcones using chiral TADDOL ligands and rare earth metal amides, offering significant cost reduction in chiral epoxide manufacturing.
Patent CN110818576B reveals a novel rare earth catalyzed synthesis of secondary amines. High yield, mild conditions, and cost-effective supply chain solutions for pharma.
Patent CN113292589B reveals a mild SmI2-catalyzed THF ring-opening method. Achieve high yields and cost reduction in fine chemical manufacturing with scalable silane synthesis.
Patent CN106423281A reveals a novel rare earth silamide catalyst for efficient spiro[cyclopropane-1,3'-indole] synthesis, offering mild conditions and cost reduction.